/
BBOT
$7.66+$0.26 (+3.51%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$592.8M
80M shares
52-week range
$7.00 – $14.87
8% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
1.64%
Moderate
Price (6 mo)
Loading chart…
Change$-1.99
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — |
| R&D | $0 | $0 | $56.3M | $73.1M | $121.2M |
| Operating income | −$43.4K | −$3.5K | −$64.8M | −$80.9M | −$145.8M |
| EBITDA | −$43.4K | −$3.5K | −$64.7M | −$80.7M | −$145.2M |
| Net income | −$43.4K | −$3.5K | −$64.7M | −$74.3M | −$134.0M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -0.00 | -0.00 | -3.16 | 0.46 | -4.30 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-2.31 | $-2.83–$-1.79 | 7 |
| 2027 | $29M | $-2.20 | $-2.51–$-1.90 | 6 |
| 2028 | $0 | $-2.26 | $-2.81–$-1.57 | 8 |
| 2029 | $28M | $-2.13 | $-2.13–$-2.13 | 6 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$11.88
Price
$7.66
Implied upside
+55%
Peer comparison
BridgeBio Oncology Therapeutics, Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
www.bridgebio.com- Employees
- 106
- IPO / List date
- Aug 12, 2025
- HQ
- SOUTH SAN FRANCISCO, CA
Held by traders on TradeandTell
No one on the platform currently holds BBOT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 101,900 | $912.0K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BBOT yet.
